Mostrando ítems 1-6 de 6
Banús Mulet, Antònia (Fecha de defensa: 2019-07-16)
Recentment s’han descrit els receptors de dopamina per la seva implicació en càncer i la seva potencial inhibició com a mecanisme antitumoral. Al present treball s’ha ampliat aquesta recerca a la LLA-T, ...
Domostegui Fernández, Ana (Fecha de defensa: 2019-12-05)
The oncogene MYC is altered and its expression is deregulated in up to 70% of human cancers, including B cell neoplasms. Earlier studies in a mouse model of Eμ-MYC-driven B-cell lymphomas reported that ...
Balcells Nadal, Cristina (Fecha de defensa: 2019-12-19)
Metastasis and drug resistance represent the two main causes of therapeutic failure in oncology. In the present dissertation, the interplay between them has been interrogated using metabolomics, systems ...
Sostoa Pomés, Jana de (Fecha de defensa: 2019-05-31)
Oncolytic virus (OV)-based therapies have an emerging role in the treatment of solid tumors, involving both direct cell lysis and immunogenic cell death. Nonetheless, tumor- associated stroma limits the ...
Bernat Peguera, Adrià (Fecha de defensa: 2019-09-20)
La mayoría de los carcinomas escamosos de piel (cSCCs) se tratan con éxito mediante escisión quirúrgica. Sin embargo, el 5-8% de los casos desarrollan recurrencias, las cuales están asociadas a un ...
Sallaberry Pinto, Júlia (Fecha de defensa: 2019-03-22)
Local invasion is a key cell-biological event in the metastatic cascade. In response to a changing microenvironment, cancer cells may act using two main strategies of invasion: single cell invasion and ...